Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
A rogue B.C. acupuncturist has been found in contempt of court for practising unlicensed needlework. A B.C. Supreme Court ...
The Burlington needle exchange program will undergo a study in the coming months, addressing the growing problem of syringes littered on city streets in conjunction with the growing drug crisis.
Dr Elizabeth Robertson, Diabetes UK’s director of research, said: “Dr Reith’s idea, and her determination to bring the insulin pen to life, changed the face of insulin therapy and diabetes care ...
Martin Short and Meryl Streep at the 2024 Emmy Awards. Their are-they-or-arent'-they flirtation has delighted fans. Danny Moloshok /Invision/AP It’s complicated — but something’s gotta give.
Three-time world champion Kaori Sakamoto of Japan leads after the short program in her Grand Prix season debut at Skate Canada. Sakamoto, the first woman to win three consecutive world titles since ...
Broome's current Needle and Syringe Program (NSP) will be transferred into an exchange. It comes after residents expressed concerns over the number of discarded needles in public spaces.
“Doctor Odyssey,” TV hitmaker Ryan Murphy’s new network medical drama set on a cruise ship, has already featured a syphilis outbreak, a nose falling off a woman’s face, a man overboard, a ...
Jacobson says the town is now seeing an unprecedented number of discarded syringes. Swan River Mayor Lance Jacobson says cleaning up discarded needles is costly for taxpayers. (Chelsea Kemp/CBC ...
Manufacturing delays will cause the Novo Nordisk's Fiasp vials to be in short supply through October, a spokesperson said. Earlier this year, the drugmaker reported shortages of NovoLog insulin.
Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply. Novo Nordisk, the manufacturer of NovoLog, also reported periodic shortages this year. The company said ...